Design of novel F-ATP synthase inhibitors of mycobacterium tuberculosis
F1FO ATP synthase of Mycobacterium tuberculosis is an attractive and intensively-studied drug target. Adenosine triphosphate (ATP) is necessary for cell growth and is vital for cell survival, especially in the case of dormant Mycobacterium. In 2012, an inhibitor of F1FO ATP synthase, Bedaquiline (BD...
Saved in:
Main Author: | Hotra, Adam |
---|---|
Other Authors: | Gerhard Gruber |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2018
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/75829 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Synthesis of Mycobacterium tuberculosis ATP synthase inhibitors
by: Pattarakiat, Seankongsuk
Published: (2022) -
Variations of subunit ε of the mycobacterium tuberculosis F1Fo ATP synthase and a novel model for mechanism of action of the tuberculosis drug TMC207
by: Rao, Srinivasa P. S., et al.
Published: (2013) -
Anti-Mycobacterium abscessus activity of tuberculosis F-ATP synthase inhibitor GaMF1
by: Ragunathan, Priya, et al.
Published: (2022) -
The role of N157 of A-ATP synthase subunit B in nucleotide binding and expression, production and structural and mechanistic features of subunits α and ε of Mycobacterium tuberculosis F-ATP synthase
by: Sundararaman, Lavanya
Published: (2016) -
Discovery of a novel mycobacterial F-ATP synthase inhibitor and its potency in combination with diarylquinolines
by: Hotra, Adam, et al.
Published: (2021)